U.S. Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, By Workflow (Pre-sequencing, Sequencing, Data Analysis), By End Use, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Technology
  • 1.1.2. Product
  • 1.1.3. Application
  • 1.1.4. Workflow
  • 1.1.5. End-use
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights

Chapter 3. U.S. Next Generation Sequencing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of cancer and genetic disorders
    • 3.2.1.2. Advancements in sequencing technologies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of computational efficiency for data management
    • 3.2.2.2. Non-value-based NGS reimbursement policy and regulation status
    • 3.2.2.3. Challenges associated with NGS implementation.
• 3.3. U.S. Next Generation Sequencing Market Analysis Tools
  • 3.3.1. SWOT analysis; by factor (political & legal, economic, and technological)
  • 3.3.2. Porter's Five Forces Analysis

Chapter 4. U.S. Next Generation Sequencing Market: Technology Business Analysis

• 4.1. Next Generation Sequencing Market: Technology Movement Analysis
• 4.2. Targeted Sequencing & Resequencing
  • 4.2.1. Targeted Sequencing & Resequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 4.2.1.1. DNA-based targeted sequencing & resequencing
      • 4.2.1.1.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.2.1.2. RNA-based targeted sequencing & resequencing
      • 4.2.1.2.1. RNA -based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
• 4.3. Whole Genome Sequencing
  • 4.3.1. Whole Genome Sequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 4.4. Whole Exome Sequencing
  • 4.4.1. Whole Exome Sequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 5. U.S. Next Generation Sequencing Market: Product Business Analysis

• 5.1. Next Generation Sequencing Market: Product Movement Analysis
• 5.2. Platforms
  • 5.2.1. Platforms Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 5.2.1.1. Sequencing
      • 5.2.1.1.1. Sequencing platforms market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.2.1.2. Data Analysis
      • 5.2.1.2.1. Data analysis platforms market estimates and forecast, 2021 - 2033 (USD Million
• 5.3. Consumables
  • 5.3.1. Consumables market estimates and forecast, 2021 - 2033 (USD million)
  • 5.3.2. Sample Preparation
    • 5.3.2.1. Sample preparation market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.3.3. Target Enrichment
    • 5.3.3.1. Target enrichment market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.3.4. Others
    • 5.3.4.1. Others market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. U.S. Next Generation Sequencing Market: Application Business Analysis

• 6.1. Next Generation Sequencing Market: Application Movement Analysis
• 6.2. Oncology
  • 6.2.1. Oncology Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 6.2.2. Diagnostics & Screening
    • 6.2.2.1. Diagnostics & screening market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.2.2.2. Oncology screening
      • 6.2.2.2.1. Oncology screening market estimates and forecast, 2021 - 2033 (USD Million)
      • 6.2.2.2.2. Sporadic cancer screening market estimates and forecast, 2021 - 2033 (USD Million)
      • 6.2.2.2.3. Inherited cancer screening market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.2.2.3. Companion diagnostics
      • 6.2.2.3.1. Companion diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.2.2.4. Other diagnostics
      • 6.2.2.4.1. Other diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.2.3. Research Studies
    • 6.2.3.1. Research studies market estimates and forecast, 2021 - 2033 (USD Million)
• 6.3. Clinical investigation
  • 6.3.1. Clinical investigation market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.3.2. Infectious Diseases
    • 6.3.2.1. Infectious diseases market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.3.3. Idiopathic Diseases
    • 6.3.3.1. Idiopathic diseases market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.3.4. Inherited Diseases
    • 6.3.4.1. Inherited diseases market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.3.5. Non-Communicable/Other Diseases
    • 6.3.5.1. Non-communicable/other diseases market estimates and forecast, 2021 - 2033 (USD Million)
• 6.4. Reproductive Health
  • 6.4.1. Reproductive Health Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 6.4.2. NIPT
    • 6.4.2.1. NIPT market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.4.2.2. Aneuploidy
      • 6.4.2.2.1. Aneuploidy market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.4.2.3. Microdeletions
      • 6.4.2.3.1. Microdeletions market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.4.3. PGT
    • 6.4.3.1. PGT market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.4.4. Newborn Genetic Screening
    • 6.4.4.1. Newborn genetic screening market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.4.5. Single Gene Analysis
    • 6.4.5.1. Single gene analysis market estimates and forecast, 2021 - 2033 (USD Million)
• 6.5. HLA Typing/Immune System Monitoring
  • 6.5.1. HLA Typing/Immune System Monitoring Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 6.6. Metagenomics, Epidemiology & Drug Development
  • 6.6.1. Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 6.7. Agrigenomics & Forensics
  • 6.7.1. Agrigenomics & Forensics Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 6.8. Consumer Genomics
  • 6.8.1. Consumer Genomics Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 7. U.S. Next Generation Sequencing Market: Workflow Business Analysis

• 7.1. Next Generation Sequencing Market: Workflow Movement Analysis
• 7.2. Pre sequencing
  • 7.2.1. Pre-Sequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 7.2.1.1. Nucleic acid extraction
      • 7.2.1.1.1. Nucleic acid extraction market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.2.1.2. Library preparation
      • 7.2.1.2.1. Library preparation market estimates and forecast, 2021 - 2033 (USD Million)
• 7.3. Sequencing
  • 7.3.1. Sequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 7.4. Data Analysis
  • 7.4.1. Data Analysis Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 7.4.2. Primary Data NGS Analysis
    • 7.4.2.1. Primary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.4.3. Secondary Data Analysis
    • 7.4.3.1. Secondary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.4.4. Tertiary Data Analysis
    • 7.4.4.1. Tertiary data analysis market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. U.S. Next Generation Sequencing Market: End Use Business Analysis

• 8.1. Next Generation Sequencing Market: End-use Movement Analysis
• 8.2. Academic Research
  • 8.2.1. Academic Research Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 8.3. Clinical Research
  • 8.3.1. Clinical Research Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 8.4. Hospitals & Clinics
  • 8.4.1. Hospitals & Clinics Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 8.5. Pharmaceutical & Biotech Entities
  • 8.5.1. Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 8.6. Other Users
  • 8.6.1. Other Users Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Market position analysis, 2024
• 9.4. Participants Overview
  • 9.4.1. Illumina, Inc
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Thermo Fisher Scientific Inc.
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Eurofins Scientific SE
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Eurofins Scientific SE
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. QIAGEN
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Quest Diagnostics Incorporated
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Azenta Life Sciences (GENEWIZ)
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. NanoString
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. PacBio
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. bioMerieux
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. BGI Group
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. F. Hoffmann-La Roche Ltd
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Product benchmarking
    • 9.4.12.4. Strategic initiatives
  • 9.4.13. ARUP Laboratories
    • 9.4.13.1. Company overview
    • 9.4.13.2. Financial performance
    • 9.4.13.3. Product benchmarking
    • 9.4.13.4. Strategic initiatives
  • 9.4.14. Novogene Co, Ltd.
    • 9.4.14.1. Company overview
    • 9.4.14.2. Financial performance
    • 9.4.14.3. Product benchmarking
    • 9.4.14.4. Strategic initiatives
  • 9.4.15. Gene by Gene Ltd.
    • 9.4.15.1. Company overview
    • 9.4.15.2. Financial performance
    • 9.4.15.3. Product benchmarking
    • 9.4.15.4. Strategic initiatives
  • 9.4.16. Lucigen Corporation
    • 9.4.16.1. Company overview
    • 9.4.16.2. Financial performance
    • 9.4.16.3. Product benchmarking
    • 9.4.16.4. Strategic initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 U.S. next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 4 U.S. next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 5 U.S. next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 6 U.S. next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 7 U.S. next generation sequencing market, by End Use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 U.S. next generation sequencing market: market outlook
• Fig. 7 U.S. next generation sequencing competitive insights.
• Fig. 8 Parent market outlook
• Fig. 9 Related/ancillary market outlook.
• Fig. 10 Penetration and growth prospect mapping
• Fig. 11 Industry value chain analysis
• Fig. 12 U.S. next generation sequencing market driver impact
• Fig. 13 U.S. next generation sequencing market restraint impact
• Fig. 14 U.S. next generation sequencing market strategic initiatives analysis
• Fig. 15 U.S. next generation sequencing market: Technology movement analysis
• Fig. 16 U.S. next generation sequencing market: Technology outlook and key takeaways
• Fig. 17 Targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 18 DNA-based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 19 RNA -based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 20 Whole genome sequencing market estimates and forecast, 2021-2033 (USD Million)
• Fig. 21 Whole exome sequencing market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 22 U.S. Next-generation sequencing market: Product outlook key takeaways
• Fig. 23 U.S. Next-generation sequencing market: Product movement analysis
• Fig. 24 Platforms market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 25 Sequencing platforms market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 26 Data analysis platforms market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 27 Consumables market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 28 Sample preparation market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 29 Target enrichment market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 30 Others market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 31 U.S. next generation sequencing Market: Application Movement Analysis
• Fig. 32 U.S. next generation sequencing market: Application outlook and key takeaways
• Fig. 33 Oncology market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 34 Diagnostics & screening market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 35 Oncology screening market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 36 Sporadic cancer screening market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 37 Inherited cancer screening market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 38 Companion diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 39 Other diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 40 Research studies market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 41 Clinical investigation market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 42 Infectious diseases market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 43 Idiopathic diseases market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 44 Inherited diseases market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 45 Non-communicable/other diseases market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 46 Reproductive health market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 47 NIPT market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 48 Aneuploidy market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 49 Microdeletions market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 50 PGT market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 51 Newborn genetic screening market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 52 Single gene analysis market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 53 HLA typing/immune system monitoring market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 54 Metagenomics, epidemiology & drug development market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 55 Agrigenomics & forensics market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 56 Consumer genomics market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 57 U.S. next generation sequencing market: workflow movement analysis
• Fig. 58 U.S. next generation sequencing market: workflow outlook and key takeaways
• Fig. 59 Pre-sequencing market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 60 Nucleic acid extraction market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 61 Library preparation market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 62 Automated library preparation market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 63 Sequencing market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 64 Data analysis market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 65 Primary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 66 Secondary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 67 Tertiary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 68 U.S. Next generation sequencing market End Use outlook key takeaways
• Fig. 69 U.S. Next-generation sequencing market: End Use movement analysis
• Fig. 70 Academic research market estimates and forecast, 2021 - 2033 (USD Million))
• Fig. 71 Clinical research market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 72 Hospitals & clinics market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 73 Pharmaceutical & biotech entities market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 74 Other users market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 75 Market share of key market players- U.S. next generation sequencing market